Stephen Wax

Company: Cullinan Therapeutics

Job title: Vice President, Clinical Development

Seminars:

Leveraging Key Learnings From CLN-978’s Clinical Studies & Regulatory Success to Better Apply Your TCE in Autoimmune Trials 9:00 am

Reviewing the clinical study design for the T-cell engager, CLN-978, to maximize the efficiency of your clinical development path – investigating where T-cell engagers are best fit in the treatment timeline for the specific modality Understanding the patient selection process and applying this a specific disease type: Do we start with healthy volunteers? Which patients…Read more

day: Day Two